ATR inhibition preferentially targets homologous recombination-deficient tumor cells

M Krajewska1, R S N Fehrmann1, P M Schoonen1

  • 1Department of Medical Onclology, University Medical Center Groningen, University of Groningen, The Netherlands.

Oncogene
|September 2, 2014
PubMed

Insights

Defective homologous recombination (HR) repair in cancer cells creates genomic instability but also reliance on ATR/Chk1 signaling. Inhibiting these pathways preferentially kills HR-deficient cancer cells, revealing potential therapeutic targets.

Area of Science:

  • Genetics
  • Cancer Biology
  • Molecular Oncology

Background:

  • Homologous recombination (HR) is crucial for repairing DNA double-strand breaks, and its defects lead to genomic instability.
  • HR-deficient cancers paradoxically survive despite genomic instability, suggesting acquired compensatory mechanisms.
  • Identifying these survival mechanisms is key to developing targeted therapies for HR-defective cancers.

Purpose of the Study:

  • To identify characteristics that enable cancer cells to survive genomic instability caused by HR defects.
  • To uncover potential therapeutic targets for HR-deficient cancers.

Main Methods:

  • Cytogenetic analysis of 1143 ovarian cancers to correlate genomic instability with replication checkpoint gene amplification (ATR, CHEK1).
  • Modeling HR deficiency by inactivating Rad51 to study its effects on replication dynamics and signaling.
  • Inhibiting ATR or Chk1 in HR-deficient cancer cells to assess their sensitivity.

Main Results:

  • Genomic instability in ovarian cancers correlated with amplification of ATR and CHEK1 genes.
  • Rad51 inactivation led to defective HR, aberrant replication, and increased ATR/Chk1-mediated replication stress signaling.
  • Inhibition of ATR or Chk1 selectively killed HR-deficient cancer cells.

Conclusions:

  • Defective HR repair induces reliance on replication checkpoint signaling (ATR/Chk1).
  • ATR and Chk1 inhibitors show preferential efficacy against HR-deficient cancer cells.
  • Replication checkpoint kinases represent promising therapeutic targets for HR-defective cancers.

Related Concept Videos

Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
58.6K
Homologous Recombination02:31

Homologous Recombination

6.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
5.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.8K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K